Risk Adapted Antifungal Strategy In Allogeneic Stem Cell Transplantation. Should We Change The Current Guidelines?
BLOOD(2019)
Abstract
Background: Current guidelines recommend the use of antifungal prophylaxis during, at least, the first three months post allogeneic stem cell transplantation (allo-SCT). However, these drugs are not exempt of adverse effects due to their own toxicity or drug-drug interactions. In addition, breakthrough mold infections seem to be emerging as a new problem in this setting.
MoreTranslated text
Key words
antifungal strategy,allogeneic stem cell transplantation,current guidelines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined